Product category
Neurology & Psychiatry
10 public development records. Search this category and review proposed presentations, evidence limits and attributed references.
- Records
- 10
- Medicines
- 10
- Devices / diagnostics
- 0
- Presentations represented
- 2
Public development records
Neurology & Psychiatry records
Category placement supports navigation. It does not establish an approved indication, suitability for a particular patient group, prescription status or eligibility for supply.
Showing 10 of 10 records
Portfolio records
| Record | Dosage form / type | Proposed strength / configuration | Proposed pack | Status |
|---|---|---|---|---|
| Amitriptyline TabletsLP-152 | TabletMedicine | 10 mg; 25 mg | Blister 10 x 10 tablets | Development record |
| Carbamazepine TabletsLP-153 | TabletMedicine | 100 mg; 200 mg; 400 mg controlled-release | Blister 10 x 10 tablets | Development record |
| Diazepam TabletsLP-159 | TabletMedicine | 2 mg; 5 mg; 10 mg | Blister 10 x 10 tablets | Development record |
| Fluoxetine CapsulesLP-154 | CapsuleMedicine | 20 mg | Blister 10 x 10 capsules | Development record |
| Haloperidol TabletsLP-160 | TabletMedicine | 1.5 mg; 5 mg | Blister/bottle | Development record |
| Phenobarbital TabletsLP-161 | TabletMedicine | 30 mg; 60 mg; 100 mg | Blister/bottle | Development record |
| Phenytoin CapsulesLP-155 | CapsuleMedicine | 100 mg | Blister 10 x 10 capsules | Development record |
| Risperidone TabletsLP-156 | TabletMedicine | 1 mg; 2 mg; 4 mg | Blister 10 x 10 tablets | Development record |
| Sertraline TabletsLP-157 | TabletMedicine | 50 mg; 100 mg | Blister 10 x 10 tablets | Development record |
| Sodium valproate TabletsLP-158 | TabletMedicine | 200 mg; 500 mg | Blister/bottle | Development record |
No matching record.
Try a broader generic name, another presentation or a portfolio reference.
Professional enquiries
Enquire about this product category.
Include the generic name or portfolio reference, your organisation and destination country.